Monoclonal Antibodies: Production, Therapeutic Applications and Real World Case Study in Cancer Management

Authors: J.Mohana Mithra, Abhisek Mund

DOI: https://doi.org/10.37082/IJIRMPS.v13.i5.232762

Short DOI: https://doi.org/g97ffb

Country: India

Full-text Research PDF File:   View   |   Download

Abstract: Monoclonal antibodies (mAbs) have emerged as one of the most important tools in modern medicine, combining scientific precision with lifesaving applications. This project explores their biology, production techniques, and industrial as well as therapeutic uses. Beginning with an overview of antibodies and the discovery of B lymphocytes are responsible for their production, the study highlights how monoclonal antibody technology was developed through hybridoma methods and later scaled in to industrial production.
The project further examines the therapeutic importance of monoclonal antibodies with a special focus on cancer management, autoimmune disease and diagnostic tools. Real – world aspects such as cost, accessibility in India and expanding global market are also discussed. A case study on breast cancer has been included to illustrate how monoclonal antibodies are applied in practice, supported by clinical outcomes and industry data.
Overall, this project emphasizes how a laboratory breakthrough transformed into a global healthcare solution. By combining biological principles, industrial data, and real clinical insights, the work provides a complete picture of how monoclonal antibodies are shaping the future of medicine.

Keywords:

Paper Id: 232762

Published On: 2025-10-20

Published In: Volume 13, Issue 5, September-October 2025

Share this